{"id":16025,"date":"2024-03-06T12:39:54","date_gmt":"2024-03-06T15:39:54","guid":{"rendered":"https:\/\/jm-metropole.com.br\/site\/?p=16025"},"modified":"2024-03-06T12:39:54","modified_gmt":"2024-03-06T15:39:54","slug":"covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente","status":"publish","type":"post","link":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/","title":{"rendered":"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente"},"content":{"rendered":"<h3 class=\"col-10 offset-1 animated fadeInDown dealy-900 display-8 display-md-8 alt-font font-italic my-1 text-center\">Decis\u00e3o foi anunciada hoje, em Bras\u00edlia<\/h3>\n<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) anunciou, nesta quarta-feira (6), em Bras\u00edlia, o\u00a0<a href=\"http:\/\/www.in.gov.br\/en\/web\/dou\/-\/resolucao-re-n-875-de-5-de-marco-de-2024-546745425\" target=\"_blank\" rel=\"noopener\">registro da vacina Spikevax<\/a>, dose monovalente contra a covid-19. Segundo a ag\u00eancia, o imunizante est\u00e1 atualizado para proteger contra a variante XBB 1.5 da covid, conhecida popularmente como Kraken.<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1584394&amp;o=node\" \/><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1584394&amp;o=node\" \/><\/p>\n<p>O produto \u00e9 registrado pela empresa Adium S.A. e fabricado pela Moderna. Segundo a Anvisa, esta \u00e9 a segunda vacina monovalente atualizada com a variante Kraken e autorizada pela ag\u00eancia. A dose est\u00e1 indicada para imuniza\u00e7\u00e3o ativa em crian\u00e7as a partir de seis meses de idade e adultos, conforme as seguintes posologias:<\/p>\n<p>&#8211; crian\u00e7as de seis meses a quatro anos sem vacina\u00e7\u00e3o pr\u00e9via e sem hist\u00f3rico conhecido de infec\u00e7\u00e3o pela covid-19: duas doses de 0,25 mililitros (ml) cada, administradas via intramuscular. A segunda dose deve ser administrada 28 dias ap\u00f3s a primeira dose.<\/p>\n<p>&#8211; crian\u00e7as de seis meses a quatro anos com vacina\u00e7\u00e3o pr\u00e9via ou com hist\u00f3rico conhecido de infec\u00e7\u00e3o por covid-19: uma dose de 0,25 ml, administrada via intramuscular, sendo que a Spikevax deve ser administrada pelo menos tr\u00eas meses ap\u00f3s a dose mais recente de qualquer vacina contra a covid.<\/p>\n<p>&#8211; crian\u00e7as de cinco a 11 anos, com ou sem vacina\u00e7\u00e3o pr\u00e9via: uma dose de 0,25 ml, administrada via intramuscular.<\/p>\n<p>&#8211; indiv\u00edduos com idade igual ou superior a 12 anos, com ou sem vacina\u00e7\u00e3o pr\u00e9via: uma dose de 0,5 ml, administrada via intramuscular.<\/p>\n<p>&#8211; adultos com 65 anos ou mais: uma dose de 0,5 ml, administrada via intramuscular. Uma dose adicional pode ser administrada, pelo menos tr\u00eas meses ap\u00f3s a dose mais recente de qualquer vacina contra a covid-19.<\/p>\n<h2>Entenda<\/h2>\n<p>O in\u00edcio e a continuidade do esquema vacinal contra a covid-19, ou seja, as duas primeiras doses e tamb\u00e9m o refor\u00e7o, s\u00e3o feitos com vacinas monovalentes.<\/p>\n<p>J\u00e1 as vacinas bivalentes contra a covid-19 atualmente s\u00e3o aplicadas em quem j\u00e1 recebeu pelo menos duas doses monovalentes pr\u00e9vias.<\/p>\n<p>*Com informa\u00e7\u00f5es de Ag\u00eancia Brasil<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Decis\u00e3o foi anunciada hoje, em Bras\u00edlia A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) anunciou, nesta quarta-feira (6), em Bras\u00edlia, o\u00a0registro da vacina Spikevax, dose monovalente contra a covid-19. Segundo a ag\u00eancia, o imunizante est\u00e1 atualizado para proteger contra a variante XBB 1.5 da covid, conhecida popularmente como Kraken. O produto \u00e9 registrado pela empresa Adium [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16026,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-16025","post","type-post","status-publish","format-standard","has-post-thumbnail","category-saude"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Covid-19: Anvisa aprova registro de vacina Spikevax monovalente - Jornal Metr\u00f3pole<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente - Jornal Metr\u00f3pole\" \/>\n<meta property=\"og:description\" content=\"Decis\u00e3o foi anunciada hoje, em Bras\u00edlia A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) anunciou, nesta quarta-feira (6), em Bras\u00edlia, o\u00a0registro da vacina Spikevax, dose monovalente contra a covid-19. Segundo a ag\u00eancia, o imunizante est\u00e1 atualizado para proteger contra a variante XBB 1.5 da covid, conhecida popularmente como Kraken. O produto \u00e9 registrado pela empresa Adium [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/\" \/>\n<meta property=\"og:site_name\" content=\"Jornal Metr\u00f3pole\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/jm.metropole\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-06T15:39:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2024\/03\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"390\" \/>\n\t<meta property=\"og:image:height\" content=\"240\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jornal Metr\u00f3pole\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jornal Metr\u00f3pole\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/\"},\"author\":{\"name\":\"Jornal Metr\u00f3pole\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#\\\/schema\\\/person\\\/a438c77cefcef76c8ddbe3dcc9b238fc\"},\"headline\":\"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente\",\"datePublished\":\"2024-03-06T15:39:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/\"},\"wordCount\":357,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp\",\"articleSection\":[\"Sa\u00fade\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/\",\"url\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/\",\"name\":\"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente - Jornal Metr\u00f3pole\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp\",\"datePublished\":\"2024-03-06T15:39:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#primaryimage\",\"url\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp\",\"contentUrl\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp\",\"width\":390,\"height\":240},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/\",\"name\":\"Jornal Metr\u00f3pole\",\"description\":\"Alto Tiet\u00ea e Regi\u00e3o\",\"publisher\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#organization\",\"name\":\"Jornal Metr\u00f3pole\",\"url\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/LOGO-JM-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/LOGO-JM-scaled.jpg\",\"width\":2560,\"height\":2498,\"caption\":\"Jornal Metr\u00f3pole\"},\"image\":{\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/jm.metropole\",\"https:\\\/\\\/www.instagram.com\\\/jm.metropole\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/#\\\/schema\\\/person\\\/a438c77cefcef76c8ddbe3dcc9b238fc\",\"name\":\"Jornal Metr\u00f3pole\",\"sameAs\":[\"https:\\\/\\\/jm-metropole.com.br\\\/site\"],\"url\":\"https:\\\/\\\/jm-metropole.com.br\\\/site\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente - Jornal Metr\u00f3pole","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/","og_locale":"pt_BR","og_type":"article","og_title":"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente - Jornal Metr\u00f3pole","og_description":"Decis\u00e3o foi anunciada hoje, em Bras\u00edlia A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) anunciou, nesta quarta-feira (6), em Bras\u00edlia, o\u00a0registro da vacina Spikevax, dose monovalente contra a covid-19. Segundo a ag\u00eancia, o imunizante est\u00e1 atualizado para proteger contra a variante XBB 1.5 da covid, conhecida popularmente como Kraken. O produto \u00e9 registrado pela empresa Adium [&hellip;]","og_url":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/","og_site_name":"Jornal Metr\u00f3pole","article_publisher":"https:\/\/www.facebook.com\/jm.metropole","article_published_time":"2024-03-06T15:39:54+00:00","og_image":[{"width":390,"height":240,"url":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2024\/03\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp","type":"image\/webp"}],"author":"Jornal Metr\u00f3pole","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Jornal Metr\u00f3pole","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#article","isPartOf":{"@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/"},"author":{"name":"Jornal Metr\u00f3pole","@id":"https:\/\/jm-metropole.com.br\/site\/#\/schema\/person\/a438c77cefcef76c8ddbe3dcc9b238fc"},"headline":"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente","datePublished":"2024-03-06T15:39:54+00:00","mainEntityOfPage":{"@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/"},"wordCount":357,"commentCount":0,"publisher":{"@id":"https:\/\/jm-metropole.com.br\/site\/#organization"},"image":{"@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#primaryimage"},"thumbnailUrl":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2024\/03\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp","articleSection":["Sa\u00fade"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/","url":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/","name":"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente - Jornal Metr\u00f3pole","isPartOf":{"@id":"https:\/\/jm-metropole.com.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#primaryimage"},"image":{"@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#primaryimage"},"thumbnailUrl":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2024\/03\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp","datePublished":"2024-03-06T15:39:54+00:00","breadcrumb":{"@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#primaryimage","url":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2024\/03\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp","contentUrl":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2024\/03\/vacinacao_contra_covid-19_sao_paulo_rovsa_abr_19012101079.webp","width":390,"height":240},{"@type":"BreadcrumbList","@id":"https:\/\/jm-metropole.com.br\/site\/covid-19-anvisa-aprova-registro-de-vacina-spikevax-monovalente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/jm-metropole.com.br\/site\/"},{"@type":"ListItem","position":2,"name":"Covid-19: Anvisa aprova registro de vacina Spikevax monovalente"}]},{"@type":"WebSite","@id":"https:\/\/jm-metropole.com.br\/site\/#website","url":"https:\/\/jm-metropole.com.br\/site\/","name":"Jornal Metr\u00f3pole","description":"Alto Tiet\u00ea e Regi\u00e3o","publisher":{"@id":"https:\/\/jm-metropole.com.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jm-metropole.com.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/jm-metropole.com.br\/site\/#organization","name":"Jornal Metr\u00f3pole","url":"https:\/\/jm-metropole.com.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jm-metropole.com.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2026\/05\/LOGO-JM-scaled.jpg","contentUrl":"https:\/\/jm-metropole.com.br\/site\/wp-content\/uploads\/2026\/05\/LOGO-JM-scaled.jpg","width":2560,"height":2498,"caption":"Jornal Metr\u00f3pole"},"image":{"@id":"https:\/\/jm-metropole.com.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/jm.metropole","https:\/\/www.instagram.com\/jm.metropole\/"]},{"@type":"Person","@id":"https:\/\/jm-metropole.com.br\/site\/#\/schema\/person\/a438c77cefcef76c8ddbe3dcc9b238fc","name":"Jornal Metr\u00f3pole","sameAs":["https:\/\/jm-metropole.com.br\/site"],"url":"https:\/\/jm-metropole.com.br\/site\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/posts\/16025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/comments?post=16025"}],"version-history":[{"count":1,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/posts\/16025\/revisions"}],"predecessor-version":[{"id":16027,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/posts\/16025\/revisions\/16027"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/media\/16026"}],"wp:attachment":[{"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/media?parent=16025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/categories?post=16025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jm-metropole.com.br\/site\/wp-json\/wp\/v2\/tags?post=16025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}